Pharmaceutical

WHO warns of “harmful” fake Ozempic in circulation in Americas and Europe

Both Novo Nordisk and Eli Lilly have filed lawsuits against unapproved sellers of their diabetes and weight loss drugs.

Jun 22, 2024 - 04:00
WHO warns of “harmful” fake Ozempic in circulation in Americas and Europe
Both Novo Nordisk and Eli Lilly have filed lawsuits against unapproved sellers of their diabetes and weight loss drugs.
Read the original article

Tags:

Previous Article

Tectonic bets on GPCR heart failure drug following reverse merger with Avrobio

Next Article

South Korea seeks to accelerate drug reimbursement administration process

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: FDA seeks to regulate lab-developed tests, closing the ‘Theranos loophole’

STAT+: FDA seeks to regulate lab-developed tests, closi...

Sep 30, 2023

STAT+: Senator calls for probe of conflict of interest on federal panel overseeing dietary guidelines

STAT+: Senator calls for probe of conflict of interest ...

Mar 20, 2023

Opinion: Contact sports cause CTE. So why are Americans watching more football than ever?

Opinion: Contact sports cause CTE. So why are Americans...

Feb 9, 2024